Literature DB >> 34338550

Single-Nucleotide Polymorphisms within the cps Loci: Another Potential Source of Clinically Important Genetic Variation for Streptococcus pneumoniae?

Jeremy S Brown1.   

Abstract

The Streptococcus pneumoniae capsule is essential for disease pathogenesis, suggesting that even minor genetic changes within the cps locus could potentially have important consequences. Arends et al. (D. W. Arends, W. R. Miellet, J. D. Langereis, T. H. A. Ederveen, et al., Infect Immun 89:e00246-21, 2021, https://doi.org/10.1128/IAI.00246-21) have identified 79 different nonsynonymous single-nucleotide polymorphisms (SNPs) in the cps locus of 338 19A serotype strains and shown significant variations between strains in nucleotide sugar content and capsule shedding. Further work is required to characterize whether any of these changes have important functional consequences on capsule-host interactions.

Entities:  

Keywords:  Streptococcus pneumoniae; capsule; phenotype; single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2021        PMID: 34338550      PMCID: PMC8519266          DOI: 10.1128/IAI.00374-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.

Authors:  J O Kim; J N Weiser
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

3.  Control of capsular polysaccharide chain length by UDP-sugar substrate concentrations in Streptococcus pneumoniae.

Authors:  Christy L Ventura; Robert T Cartee; W Thomas Forsee; Janet Yother
Journal:  Mol Microbiol       Date:  2006-06-15       Impact factor: 3.501

4.  Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.

Authors:  Aaron L Nelson; Aoife M Roche; Jane M Gould; Kannie Chim; Adam J Ratner; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

5.  Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype.

Authors:  Catherine Hyams; Jose Yuste; Katie Bax; Emilie Camberlein; Jeffrey N Weiser; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

6.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

7.  Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.

Authors:  Catherine Hyams; Krzysztof Trzcinski; Emilie Camberlein; Daniel M Weinberger; Suneeta Chimalapati; Mahdad Noursadeghi; Marc Lipsitch; Jeremy S Brown
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

8.  Effects of Streptococcus pneumoniae strain background on complement resistance.

Authors:  Catherine Hyams; Sophia Opel; William Hanage; Jose Yuste; Katie Bax; Birgitta Henriques-Normark; Brian G Spratt; Jeremy S Brown
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

9.  Capsular Polysaccharide Expression in Commensal Streptococcus Species: Genetic and Antigenic Similarities to Streptococcus pneumoniae.

Authors:  Uffe B Skov Sørensen; Kaihu Yao; Yonghong Yang; Hervé Tettelin; Mogens Kilian
Journal:  MBio       Date:  2016-11-15       Impact factor: 7.867

10.  Examining the Distribution and Impact of Single-Nucleotide Polymorphisms in the Capsular Locus of Streptococcus pneumoniae Serotype 19A.

Authors:  D W Arends; W R Miellet; J D Langereis; T H A Ederveen; C E van der Gaast-de Jongh; M van Scherpenzeel; M J Knol; N M van Sorge; D J Lefeber; K Trzciński; E A M Sanders; H C Dorfmueller; H J Bootsma; M I de Jonge
Journal:  Infect Immun       Date:  2021-07-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.